Editorial
Liquid biopsies come of age in lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:706-710
.
(30 May 2022)
Original Article
Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with GenexusTM integrated sequencer
Translational Lung Cancer Research
2022;
11
(5)
:711-721
.
(30 May 2022)
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:722-734
.
(30 May 2022)
Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, China
Translational Lung Cancer Research
2022;
11
(5)
:735-743
.
(30 May 2022)
Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis
Translational Lung Cancer Research
2022;
11
(5)
:744-756
.
(30 May 2022)
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study
Translational Lung Cancer Research
2022;
11
(5)
:757-775
.
(30 May 2022)
The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study
Translational Lung Cancer Research
2022;
11
(5)
:776-785
.
(30 May 2022)
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
Translational Lung Cancer Research
2022;
11
(5)
:786-801
.
(30 May 2022)
Triptolide promotes degradation of the unfolded gain-of-function Tp53R175H/Y220C mutant protein by initiating heat shock protein 70 transcription in non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:802-816
.
(30 May 2022)
An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:817-831
.
(30 May 2022)
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial
Translational Lung Cancer Research
2022;
11
(5)
:832-844
.
(30 May 2022)
Longitudinal prediction of lung nodule invasiveness by sequential modelling with common clinical computed tomography (CT) measurements: a prediction accuracy study
Translational Lung Cancer Research
2022;
11
(5)
:845-857
.
(30 May 2022)
NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma
Translational Lung Cancer Research
2022;
11
(5)
:858-868
.
(30 May 2022)
The long-term oncologic outcomes of robot-assisted bronchial single sleeve lobectomy for 104 consecutive patients with centrally located non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:869-879
.
(30 May 2022)
The strategy of non-intubated spontaneous ventilation anesthesia for upper tracheal surgery: a retrospective case series study
Translational Lung Cancer Research
2022;
11
(5)
:880-889
.
(30 May 2022)
Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients
Translational Lung Cancer Research
2022;
11
(5)
:890-901
.
(30 May 2022)
iMDT Corner
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
Translational Lung Cancer Research
2022;
11
(5)
:902-909
.
(30 May 2022)
Review Article
Are polygenic risk scores ready for the cancer clinic?—a perspective
Translational Lung Cancer Research
2022;
11
(5)
:910-919
.
(30 May 2022)
Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review
Translational Lung Cancer Research
2022;
11
(5)
:920-934
.
(30 May 2022)
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
Translational Lung Cancer Research
2022;
11
(5)
:935-949
.
(30 May 2022)
Erratum
Erratum to evaluation of PD-L1 expression on circulating tumour cells in small cell lung cancer
Translational Lung Cancer Research
2022;
11
(5)
:950-952
.
(30 May 2022)
